"datasourceId","Drug_brand_name","TA","noTarget","interactionAssociation","phenotypeAssociation","score","datasourceName","datasourceType","Year"
"cancer_biomarkers","Zuranolone","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Ublituximab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Terlipressin",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tebentafusp",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tapinarof",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Sutimlimab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","SRP-9001","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Spesolimab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","SER-109","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","RSVpreF","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Repotrectinib","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Oteseconazole","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Olorofim","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Nedosiran",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Mosunetuzumab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Lenacapavir","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","GSK3844766A","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Futibatinib",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Daridorexant",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Concizumab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Anacaulase","No human target",TRUE,NA,NA,NA,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Tremelimumab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Teplizumab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Abrocitinib",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Teclistamab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Talquetamab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Deucravacitinib",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Faricimab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Mitapivat",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Momelotinib",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Pacritinib",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Ganaxolone",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tirzepatide",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Infigratinib (Truseltiq)","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,TRUE,0.919067987742997,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Asciminib (Scemblix)","Oncology",FALSE,TRUE,TRUE,0.967152948166419,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Olutasidenib",NA,FALSE,TRUE,TRUE,0.827461363415818,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Lecanemab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Donanemab",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Vutrisiran",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.942151532920827,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Adagrasib",NA,FALSE,TRUE,TRUE,0.942151532920827,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Tofersen",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2023
"cancer_biomarkers","Mavacamten",NA,FALSE,NA,NA,0,"Cancer Biomarkers (CGI)","Somatic",2022
"cancer_biomarkers","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.968836966996368,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_biomarkers","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.968836966996368,"Cancer Biomarkers (CGI)","Somatic",2021
"cancer_gene_census","Zuranolone","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Ublituximab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Terlipressin",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tebentafusp",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tapinarof",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Sutimlimab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","SRP-9001","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Spesolimab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","SER-109","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","RSVpreF","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Repotrectinib","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Oteseconazole","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Olorofim","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Olipudase alfa","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Nedosiran",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Mosunetuzumab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Lenacapavir","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","GSK3844766A","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Gadopiclenol","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Futibatinib",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Eflapegrastim","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Daridorexant",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Concizumab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Anacaulase","No human target",TRUE,NA,NA,NA,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Tremelimumab",NA,FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Teplizumab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Abrocitinib",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Umbralisib (Ukoniq)","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Tisotumab vedotin (Tivdak)","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Teclistamab",NA,FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Talquetamab",NA,FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Belzutifan (Welireg)","Oncology",FALSE,NA,TRUE,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Deucravacitinib",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Faricimab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Dostarlimab (Jemperli)","Oncology",FALSE,TRUE,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Mitapivat",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Trilaciclib (Cosela)","Oncology",FALSE,TRUE,TRUE,0.455948098208716,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Momelotinib",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Pacritinib",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Ganaxolone",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tirzepatide",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,TRUE,0.622706893386904,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Infigratinib (Truseltiq)","Oncology",FALSE,TRUE,TRUE,0.7219178221638,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,TRUE,0.88402882441722,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Asciminib (Scemblix)","Oncology",FALSE,TRUE,TRUE,0.759913497014526,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Olutasidenib",NA,FALSE,TRUE,TRUE,0.531939447910168,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Lecanemab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Donanemab",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Vutrisiran",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.842931461823577,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Adagrasib",NA,FALSE,TRUE,TRUE,0.842931461823577,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Tofersen",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2023
"cancer_gene_census","Mavacamten",NA,FALSE,NA,NA,0,"CGC (COSMIC)","Somatic",2022
"cancer_gene_census","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.926746075358155,"CGC (COSMIC)","Somatic",2021
"cancer_gene_census","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.926746075358155,"CGC (COSMIC)","Somatic",2021
"clingen","Zuranolone","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Ublituximab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Terlipressin",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tebentafusp",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tapinarof",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Sutimlimab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","SRP-9001","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Spesolimab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","SER-109","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","RSVpreF","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Repotrectinib","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Oteseconazole","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Olorofim","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Nedosiran",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Mosunetuzumab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Lenacapavir","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","GSK3844766A","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Futibatinib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Daridorexant",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Concizumab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2021
"clingen","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2023
"clingen","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Anacaulase","No human target",TRUE,NA,NA,NA,"Clingen","Rare mendelian",2022
"clingen","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Tremelimumab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Teplizumab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Abrocitinib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Teclistamab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Talquetamab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Deucravacitinib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Faricimab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Mitapivat",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Momelotinib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Pacritinib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Ganaxolone",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tirzepatide",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"Clingen","Rare mendelian",2021
"clingen","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Olutasidenib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Lecanemab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Donanemab",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2023
"clingen","Vutrisiran",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"Clingen","Rare mendelian",2021
"clingen","Adagrasib",NA,FALSE,NA,NA,0,"Clingen","Rare mendelian",2022
"clingen","Tofersen",NA,FALSE,TRUE,TRUE,0.827461363415818,"Clingen","Rare mendelian",2023
"clingen","Mavacamten",NA,FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2022
"clingen","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2021
"clingen","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"Clingen","Rare mendelian",2021
"crispr","Zuranolone","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Ublituximab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Terlipressin",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tebentafusp",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tapinarof",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Sutimlimab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","SRP-9001","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Spesolimab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","SER-109","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","RSVpreF","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Repotrectinib","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Oteseconazole","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Olorofim","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Nedosiran",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Mosunetuzumab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Lenacapavir","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","GSK3844766A","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Futibatinib",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Daridorexant",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Concizumab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2021
"crispr","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2023
"crispr","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Anacaulase","No human target",TRUE,NA,NA,NA,"Project Score","Functional genomics (cancer)",2022
"crispr","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Tremelimumab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Teplizumab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Abrocitinib",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Teclistamab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Talquetamab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Deucravacitinib",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Faricimab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Mitapivat",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Momelotinib",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Pacritinib",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Ganaxolone",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tirzepatide",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2021
"crispr","Olutasidenib",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Lecanemab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Donanemab",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Vutrisiran",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.272428988679708,"Project Score","Functional genomics (cancer)",2021
"crispr","Adagrasib",NA,FALSE,TRUE,TRUE,0.272428988679708,"Project Score","Functional genomics (cancer)",2022
"crispr","Tofersen",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2023
"crispr","Mavacamten",NA,FALSE,NA,NA,0,"Project Score","Functional genomics (cancer)",2022
"crispr","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.378816878261741,"Project Score","Functional genomics (cancer)",2021
"crispr","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.378816878261741,"Project Score","Functional genomics (cancer)",2021
"eva","Zuranolone","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Ublituximab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Terlipressin",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tebentafusp",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tapinarof",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Sutimlimab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","SRP-9001","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Spesolimab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","SER-109","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","RSVpreF","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Repotrectinib","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Oteseconazole","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Olorofim","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Olipudase alfa","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Nedosiran",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Mosunetuzumab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Lenacapavir","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","GSK3844766A","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Gadopiclenol","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Futibatinib",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Eflapegrastim","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Daridorexant",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Concizumab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2021
"eva","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2023
"eva","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Anacaulase","No human target",TRUE,NA,NA,NA,"ClinVar","Rare mendelian",2022
"eva","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Tremelimumab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Teplizumab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Abrocitinib",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Teclistamab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Talquetamab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2023
"eva","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2021
"eva","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2021
"eva","Deucravacitinib",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Faricimab",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Mitapivat",NA,FALSE,TRUE,TRUE,0.425551558328135,"ClinVar","Rare mendelian",2022
"eva","Trilaciclib (Cosela)","Oncology",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2021
"eva","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Momelotinib",NA,FALSE,TRUE,TRUE,0.665684223384725,"ClinVar","Rare mendelian",2023
"eva","Vericiguat (Verquvo)","Other indication",FALSE,NA,TRUE,0,"ClinVar","Rare mendelian",2021
"eva","Pacritinib",NA,FALSE,TRUE,TRUE,0.665684223384725,"ClinVar","Rare mendelian",2022
"eva","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,TRUE,TRUE,0.559296333802691,"ClinVar","Rare mendelian",2021
"eva","Ganaxolone",NA,FALSE,TRUE,TRUE,0.594421224331363,"ClinVar","Rare mendelian",2022
"eva","Tirzepatide",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,TRUE,TRUE,0.968618748594972,"ClinVar","Rare mendelian",2021
"eva","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"ClinVar","Rare mendelian",2021
"eva","Asciminib (Scemblix)","Oncology",FALSE,TRUE,TRUE,0.732556611122003,"ClinVar","Rare mendelian",2021
"eva","Olutasidenib",NA,FALSE,TRUE,TRUE,0.559296333802691,"ClinVar","Rare mendelian",2022
"eva","Lecanemab",NA,FALSE,TRUE,TRUE,0.874357153360333,"ClinVar","Rare mendelian",2023
"eva","Donanemab",NA,FALSE,TRUE,TRUE,0.874357153360333,"ClinVar","Rare mendelian",2023
"eva","Vutrisiran",NA,FALSE,TRUE,TRUE,0.946899854872392,"ClinVar","Rare mendelian",2022
"eva","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"ClinVar","Rare mendelian",2021
"eva","Adagrasib",NA,FALSE,NA,NA,0,"ClinVar","Rare mendelian",2022
"eva","Tofersen",NA,FALSE,TRUE,TRUE,0.946614845449127,"ClinVar","Rare mendelian",2023
"eva","Mavacamten",NA,FALSE,TRUE,TRUE,0.967940751982116,"ClinVar","Rare mendelian",2022
"eva","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.823172073899336,"ClinVar","Rare mendelian",2021
"eva","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.823172073899336,"ClinVar","Rare mendelian",2021
"eva_somatic","Zuranolone","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Ublituximab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Terlipressin",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tebentafusp",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tapinarof",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Sutimlimab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","SRP-9001","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Spesolimab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","SER-109","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","RSVpreF","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Repotrectinib","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Oteseconazole","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Olorofim","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Olipudase alfa","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Nedosiran",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Mosunetuzumab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Lenacapavir","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","GSK3844766A","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Gadopiclenol","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Futibatinib",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Eflapegrastim","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Daridorexant",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Concizumab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Anacaulase","No human target",TRUE,NA,NA,NA,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Tremelimumab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Teplizumab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Abrocitinib",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Tisotumab vedotin (Tivdak)","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Teclistamab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Talquetamab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Deucravacitinib",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Faricimab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Mitapivat",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Trilaciclib (Cosela)","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Momelotinib",NA,FALSE,TRUE,TRUE,0.547137717850459,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Pacritinib",NA,FALSE,TRUE,TRUE,0.547137717850459,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Ganaxolone",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tirzepatide",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Asciminib (Scemblix)","Oncology",FALSE,TRUE,TRUE,0.808573424292028,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Olutasidenib",NA,FALSE,TRUE,TRUE,0.832123889357364,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Lecanemab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Donanemab",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Vutrisiran",NA,FALSE,TRUE,TRUE,0.699120417253364,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.893596278167008,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Adagrasib",NA,FALSE,TRUE,TRUE,0.893596278167008,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Tofersen",NA,FALSE,NA,NA,0,"ClinVar (Somatic)","Somatic",2023
"eva_somatic","Mavacamten",NA,FALSE,TRUE,NA,0,"ClinVar (Somatic)","Somatic",2022
"eva_somatic","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.900195720739544,"ClinVar (Somatic)","Somatic",2021
"eva_somatic","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.900195720739544,"ClinVar (Somatic)","Somatic",2021
"gene_burden","Zuranolone","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Ublituximab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Terlipressin",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tebentafusp",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tapinarof",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Sutimlimab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","SRP-9001","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Spesolimab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","SER-109","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","RSVpreF","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Repotrectinib","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Oteseconazole","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Olorofim","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Nedosiran",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Mosunetuzumab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Lenacapavir","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","GSK3844766A","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Futibatinib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Daridorexant",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Concizumab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2021
"gene_burden","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2023
"gene_burden","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Anacaulase","No human target",TRUE,NA,NA,NA,"Gene burden","Common disease",2022
"gene_burden","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Tremelimumab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Teplizumab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Abrocitinib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Teclistamab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Talquetamab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"Gene burden","Common disease",2021
"gene_burden","Deucravacitinib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Faricimab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Mitapivat",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Momelotinib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Pacritinib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Ganaxolone",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tirzepatide",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Tepotinib (Tepmetko)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Olutasidenib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Lecanemab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Donanemab",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Vutrisiran",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Adagrasib",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2022
"gene_burden","Tofersen",NA,FALSE,NA,NA,0,"Gene burden","Common disease",2023
"gene_burden","Mavacamten",NA,FALSE,TRUE,TRUE,0.69370813621813,"Gene burden","Common disease",2022
"gene_burden","Mobocertinib (Exkivity)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene_burden","Amivantamab (Rybrevant)","Oncology",FALSE,NA,NA,0,"Gene burden","Common disease",2021
"gene2phenotype","Zuranolone","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Ublituximab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Terlipressin",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tebentafusp",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tapinarof",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Sutimlimab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","SRP-9001","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Spesolimab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","SER-109","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","RSVpreF","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Repotrectinib","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Oteseconazole","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Olorofim","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Olipudase alfa","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Nedosiran",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Mosunetuzumab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Lenacapavir","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","GSK3844766A","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Gadopiclenol","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Futibatinib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Eflapegrastim","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Daridorexant",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Concizumab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Anacaulase","No human target",TRUE,NA,NA,NA,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Tremelimumab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Teplizumab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Abrocitinib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Teclistamab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Talquetamab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Deucravacitinib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Faricimab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Mitapivat",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Momelotinib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Pacritinib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Ganaxolone",NA,FALSE,TRUE,TRUE,0.607930797611621,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tirzepatide",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Tepotinib (Tepmetko)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Olutasidenib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Lecanemab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Donanemab",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Vutrisiran",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Adagrasib",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Tofersen",NA,FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2023
"gene2phenotype","Mavacamten",NA,FALSE,TRUE,TRUE,0.607930797611621,"gene2phenotype","Rare mendelian",2022
"gene2phenotype","Mobocertinib (Exkivity)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"gene2phenotype","Amivantamab (Rybrevant)","Oncology",FALSE,NA,NA,0,"gene2phenotype","Rare mendelian",2021
"genomics_england","Zuranolone","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Ublituximab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Terlipressin",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tebentafusp",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tapinarof",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Sutimlimab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","SRP-9001","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Spesolimab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","SER-109","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","RSVpreF","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Repotrectinib","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Oteseconazole","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Olorofim","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Olipudase alfa","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Nedosiran",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Mosunetuzumab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Lenacapavir","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","GSK3844766A","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Gadopiclenol","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Futibatinib",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Eflapegrastim","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Daridorexant",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Concizumab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Anacaulase","No human target",TRUE,NA,NA,NA,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Tremelimumab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Teplizumab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Abrocitinib",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Teclistamab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Talquetamab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Deucravacitinib",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Faricimab",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Mitapivat",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Momelotinib",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Pacritinib",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Ganaxolone",NA,FALSE,TRUE,TRUE,0.759913497014526,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tirzepatide",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Tepotinib (Tepmetko)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Asciminib (Scemblix)","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Olutasidenib",NA,FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Lecanemab",NA,FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Donanemab",NA,FALSE,TRUE,TRUE,0.607930797611621,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Vutrisiran",NA,FALSE,TRUE,TRUE,0.939111878932769,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Adagrasib",NA,FALSE,TRUE,NA,0,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Tofersen",NA,FALSE,TRUE,TRUE,0.759913497014526,"GEL PanelApp","Rare mendelian",2023
"genomics_england","Mavacamten",NA,FALSE,TRUE,TRUE,0.947175754388692,"GEL PanelApp","Rare mendelian",2022
"genomics_england","Mobocertinib (Exkivity)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"genomics_england","Amivantamab (Rybrevant)","Oncology",FALSE,NA,NA,0,"GEL PanelApp","Rare mendelian",2021
"impc","Zuranolone","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Ublituximab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Terlipressin",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Tebentafusp",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Tapinarof",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Sutimlimab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","SRP-9001","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Spesolimab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","SER-109","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","RSVpreF","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Repotrectinib","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Oteseconazole","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Olorofim","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Nedosiran",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2023
"impc","Mosunetuzumab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Lenacapavir","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","GSK3844766A","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Futibatinib",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Daridorexant",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Concizumab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2023
"impc","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2021
"impc","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2023
"impc","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Anacaulase","No human target",TRUE,NA,NA,NA,"Mouse model (IMPC)",NA,2022
"impc","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Tremelimumab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Teplizumab",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Abrocitinib",NA,FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Umbralisib (Ukoniq)","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Teclistamab",NA,FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Talquetamab",NA,FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2023
"impc","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,TRUE,0,"Mouse model (IMPC)",NA,2021
"impc","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Deucravacitinib",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Faricimab",NA,FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Mitapivat",NA,FALSE,TRUE,TRUE,0.261653415292042,"Mouse model (IMPC)",NA,2022
"impc","Trilaciclib (Cosela)","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,TRUE,TRUE,0.818087408255978,"Mouse model (IMPC)",NA,2021
"impc","Tralokinumab (Adbry)","Other indication",FALSE,TRUE,TRUE,0.347440894318342,"Mouse model (IMPC)",NA,2021
"impc","Momelotinib",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2023
"impc","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Pacritinib",NA,FALSE,TRUE,TRUE,0.269070171022903,"Mouse model (IMPC)",NA,2022
"impc","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Ganaxolone",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Tirzepatide",NA,FALSE,TRUE,TRUE,0.787954305054362,"Mouse model (IMPC)",NA,2022
"impc","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,TRUE,TRUE,0.484040698575115,"Mouse model (IMPC)",NA,2021
"impc","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,TRUE,0.346642140798146,"Mouse model (IMPC)",NA,2021
"impc","Asciminib (Scemblix)","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Olutasidenib",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Lecanemab",NA,FALSE,TRUE,TRUE,0.439468951851791,"Mouse model (IMPC)",NA,2023
"impc","Donanemab",NA,FALSE,TRUE,TRUE,0.439468951851791,"Mouse model (IMPC)",NA,2023
"impc","Vutrisiran",NA,FALSE,NA,NA,0,"Mouse model (IMPC)",NA,2022
"impc","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.415551096707424,"Mouse model (IMPC)",NA,2021
"impc","Adagrasib",NA,FALSE,TRUE,TRUE,0.415551096707424,"Mouse model (IMPC)",NA,2022
"impc","Tofersen",NA,FALSE,TRUE,TRUE,0.438443676561619,"Mouse model (IMPC)",NA,2023
"impc","Mavacamten",NA,FALSE,TRUE,TRUE,0.414794138429564,"Mouse model (IMPC)",NA,2022
"impc","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,NA,0,"Mouse model (IMPC)",NA,2021
"impc","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.346642140798146,"Mouse model (IMPC)",NA,2021
"intogen","Zuranolone","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Ublituximab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Terlipressin",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tebentafusp",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tapinarof",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Sutimlimab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","SRP-9001","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Spesolimab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","SER-109","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","RSVpreF","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Repotrectinib","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Oteseconazole","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Olorofim","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Olipudase alfa","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Nedosiran",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Mosunetuzumab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Lenacapavir","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","GSK3844766A","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Gadopiclenol","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Futibatinib",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Eflapegrastim","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Daridorexant",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Concizumab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2021
"intogen","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2023
"intogen","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Anacaulase","No human target",TRUE,NA,NA,NA,"IntOgen","Somatic",2022
"intogen","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Tremelimumab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Teplizumab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Abrocitinib",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Tisotumab vedotin (Tivdak)","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Teclistamab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Talquetamab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Deucravacitinib",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Faricimab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Mitapivat",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Trilaciclib (Cosela)","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Momelotinib",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Pacritinib",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Ganaxolone",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tirzepatide",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Infigratinib (Truseltiq)","Oncology",FALSE,TRUE,TRUE,0.322779459545566,"IntOgen","Somatic",2021
"intogen","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"IntOgen","Somatic",2021
"intogen","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"IntOgen","Somatic",2021
"intogen","Olutasidenib",NA,FALSE,TRUE,TRUE,0.801779693110174,"IntOgen","Somatic",2022
"intogen","Lecanemab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Donanemab",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Vutrisiran",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.865457038266544,"IntOgen","Somatic",2021
"intogen","Adagrasib",NA,FALSE,TRUE,TRUE,0.865457038266544,"IntOgen","Somatic",2022
"intogen","Tofersen",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2023
"intogen","Mavacamten",NA,FALSE,NA,NA,0,"IntOgen","Somatic",2022
"intogen","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.850675779255117,"IntOgen","Somatic",2021
"intogen","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.850675779255117,"IntOgen","Somatic",2021
"orphanet","Zuranolone","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Ublituximab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Terlipressin",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tebentafusp",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tapinarof",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Sutimlimab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","SRP-9001","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Spesolimab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","SER-109","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","RSVpreF","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Repotrectinib","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Oteseconazole","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Olorofim","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Nedosiran",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Mosunetuzumab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Lenacapavir","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","GSK3844766A","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Futibatinib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Daridorexant",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Concizumab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2021
"orphanet","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2023
"orphanet","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Anacaulase","No human target",TRUE,NA,NA,NA,"Orphanet","Rare mendelian",2022
"orphanet","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Tremelimumab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Teplizumab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Abrocitinib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Teclistamab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Talquetamab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,TRUE,0,"Orphanet","Rare mendelian",2021
"orphanet","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"Orphanet","Rare mendelian",2021
"orphanet","Deucravacitinib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Faricimab",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Mitapivat",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Momelotinib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2023
"orphanet","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Pacritinib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Ganaxolone",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tirzepatide",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Tepotinib (Tepmetko)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Olutasidenib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Lecanemab",NA,FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2023
"orphanet","Donanemab",NA,FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2023
"orphanet","Vutrisiran",NA,FALSE,TRUE,TRUE,0.759913497014526,"Orphanet","Rare mendelian",2022
"orphanet","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Adagrasib",NA,FALSE,NA,NA,0,"Orphanet","Rare mendelian",2022
"orphanet","Tofersen",NA,FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2023
"orphanet","Mavacamten",NA,FALSE,TRUE,TRUE,0.607930797611621,"Orphanet","Rare mendelian",2022
"orphanet","Mobocertinib (Exkivity)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"orphanet","Amivantamab (Rybrevant)","Oncology",FALSE,NA,NA,0,"Orphanet","Rare mendelian",2021
"ot_genetics_portal","Zuranolone","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Ublituximab",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Terlipressin",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tebentafusp",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tapinarof",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Sutimlimab",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","SRP-9001","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Spesolimab",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","SER-109","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","RSVpreF","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Repotrectinib","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Oteseconazole","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Olorofim","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Olipudase alfa","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Nedosiran",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Mosunetuzumab",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Lenacapavir","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","GSK3844766A","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Gadopiclenol","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Futibatinib",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Eflapegrastim","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Daridorexant",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Concizumab",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Anacaulase","No human target",TRUE,NA,NA,NA,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Tremelimumab",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Teplizumab",NA,FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Abrocitinib",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Odevixibat (Bylvay)","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Maralixibat (Livmarli)","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Finerenone (Kerendia)","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Teclistamab",NA,FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Talquetamab",NA,FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Belzutifan (Welireg)","Oncology",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Deucravacitinib",NA,FALSE,TRUE,TRUE,0.322750665204322,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Faricimab",NA,FALSE,TRUE,TRUE,0.457998843449737,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Inclisiran (Leqvio)","Other indication",FALSE,TRUE,TRUE,0.58039748904511,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Mitapivat",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Tralokinumab (Adbry)","Other indication",FALSE,TRUE,TRUE,0.724050378449981,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Momelotinib",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Vericiguat (Verquvo)","Other indication",FALSE,TRUE,TRUE,0.806689170321755,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Pacritinib",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,TRUE,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Ganaxolone",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tirzepatide",NA,FALSE,TRUE,TRUE,0.815605635144139,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Olutasidenib",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Lecanemab",NA,FALSE,TRUE,TRUE,0.582216982168431,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Donanemab",NA,FALSE,TRUE,TRUE,0.582216982168431,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Vutrisiran",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Adagrasib",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Tofersen",NA,FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2023
"ot_genetics_portal","Mavacamten",NA,FALSE,NA,NA,0,"OT Genetics Portal","Common disease",2022
"ot_genetics_portal","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"ot_genetics_portal","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,NA,0,"OT Genetics Portal","Common disease",2021
"progeny","Zuranolone","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Ublituximab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Terlipressin",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tebentafusp",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tapinarof",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Sutimlimab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","SRP-9001","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Spesolimab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","SER-109","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","RSVpreF","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Repotrectinib","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Oteseconazole","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Olorofim","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Nedosiran",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Mosunetuzumab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Lenacapavir","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","GSK3844766A","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Futibatinib",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Daridorexant",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Concizumab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2021
"progeny","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2023
"progeny","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Anacaulase","No human target",TRUE,NA,NA,NA,"Progeny","Functional genomics (cancer)",2022
"progeny","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Tremelimumab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Teplizumab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Abrocitinib",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Teclistamab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Talquetamab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Deucravacitinib",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Faricimab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Mitapivat",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Momelotinib",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Pacritinib",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Ganaxolone",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tirzepatide",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,TRUE,0.611001138042729,"Progeny","Functional genomics (cancer)",2021
"progeny","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Olutasidenib",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Lecanemab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Donanemab",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Vutrisiran",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2021
"progeny","Adagrasib",NA,FALSE,TRUE,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Tofersen",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2023
"progeny","Mavacamten",NA,FALSE,NA,NA,0,"Progeny","Functional genomics (cancer)",2022
"progeny","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.593265567332442,"Progeny","Functional genomics (cancer)",2021
"progeny","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.593265567332442,"Progeny","Functional genomics (cancer)",2021
"slapenrich","Zuranolone","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Ublituximab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Terlipressin",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tebentafusp",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tapinarof",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Sutimlimab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","SRP-9001","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Spesolimab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","SER-109","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","RSVpreF","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Repotrectinib","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Oteseconazole","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Olorofim","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Olipudase alfa","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Nedosiran",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Mosunetuzumab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Lenacapavir","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","GSK3844766A","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Gadopiclenol","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Futibatinib",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Eflapegrastim","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Daridorexant",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Concizumab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Anacaulase","No human target",TRUE,NA,NA,NA,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Tremelimumab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Teplizumab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Abrocitinib",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Teclistamab",NA,FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Talquetamab",NA,FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Belzutifan (Welireg)","Oncology",FALSE,NA,TRUE,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Vosoritide (Voxzogo)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Deucravacitinib",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Faricimab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Dostarlimab (Jemperli)","Oncology",FALSE,TRUE,TRUE,0.607930797611621,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Mitapivat",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Trilaciclib (Cosela)","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Momelotinib",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Pacritinib",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Ganaxolone",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tirzepatide",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tivozanib (Fotivda)","Oncology",FALSE,TRUE,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,TRUE,0.957622468381807,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Olutasidenib",NA,FALSE,TRUE,TRUE,0.76516056090965,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Lecanemab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Donanemab",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Vutrisiran",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,TRUE,0.989052667521338,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Adagrasib",NA,FALSE,TRUE,TRUE,0.989052667521338,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Tofersen",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2023
"slapenrich","Mavacamten",NA,FALSE,NA,NA,0,"SlapEnrich","Functional genomics (cancer)",2022
"slapenrich","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.977654451498777,"SlapEnrich","Functional genomics (cancer)",2021
"slapenrich","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.977654451498777,"SlapEnrich","Functional genomics (cancer)",2021
"uniprot_literature","Zuranolone","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Ublituximab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Terlipressin",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tebentafusp",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tapinarof",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Sutimlimab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","SRP-9001","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Spesolimab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","SER-109","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","RSVpreF","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Repotrectinib","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Oteseconazole","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Olorofim","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Nedosiran",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Mosunetuzumab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Lenacapavir","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","GSK3844766A","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Futibatinib",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Daridorexant",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Concizumab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Anacaulase","No human target",TRUE,NA,NA,NA,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Tremelimumab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Teplizumab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Abrocitinib",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Teclistamab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Talquetamab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Deucravacitinib",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Faricimab",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Mitapivat",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Momelotinib",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Pacritinib",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Ganaxolone",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tirzepatide",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Tepotinib (Tepmetko)","Oncology",FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Olutasidenib",NA,FALSE,NA,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Lecanemab",NA,FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Donanemab",NA,FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Vutrisiran",NA,FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Sotorasib (Lumakras)","Oncology",FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Adagrasib",NA,FALSE,TRUE,NA,0,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Tofersen",NA,FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2023
"uniprot_literature","Mavacamten",NA,FALSE,TRUE,TRUE,0.607930797611621,"Uniprot (gene-disease)","Rare mendelian",2022
"uniprot_literature","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_literature","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,TRUE,0.759913497014526,"Uniprot (gene-disease)","Rare mendelian",2021
"uniprot_variants","Zuranolone","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Xenon Xe 129 hyperpolarized","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Vonoprazan; amoxicillin; clarithromycin","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Voclosporin (Lupkynis)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Viloxazine (Qelbree)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Valoctocogene roxaparvovec","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Ublituximab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tezepelumab (Tezspire)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Terlipressin",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tebentafusp",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tapinarof",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Sutimlimab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","SRP-9001","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Spesolimab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Sodium phenylbutyrate; taurursodiol","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","SER-109","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","RSVpreF","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Repotrectinib","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Relatlimab; nivolumab","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Ponesimod (Ponvory)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Piflufolastat F-18 (Pylarify)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Pegcetacoplan (Empaveli)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Pafolacianine (Cytalux)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Oteseconazole","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Omidenepag isopropyl",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Olorofim","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Olipudase alfa","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Olanzapine; samidorphan (Lybalvi)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Nedosiran",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Mosunetuzumab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Mirvetuximab soravtansine",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Melphalan flufenamide (Pepaxto)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Maribavir (Livtencity)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Lutetium Lu-177 vipivotide tetraxetan",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Loncastuximab tesirine (Zynlonta)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Lenacapavir","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Ibrexafungerp (Brexafemme)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","GSK3844766A","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Gadopiclenol","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Futibatinib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Fosdenopterin (Nulibry)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Fexinidazole (Fexinidazole)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Exagamglogene autotemcel","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Evinacumab (Evkeeza)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Eflapegrastim","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Efgartigimod alfa (Vyvgart)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Efanesoctocog alfa","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Drospirenone; estetrol (Nextstellis)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Difelikefalin (Korsuva)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","DaxibotulinumtoxinA",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Daridorexant",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Concizumab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Casimersen (Amondys 45)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Cabotegravir; rilpivirine (Cabenuva Kit)","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Bercolagene telserpavec","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Belumosudil (Rezurock)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Avacopan (Tavneos)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Atogepant (Qulipta)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Asparaginase erwinia chrysanthemi (Rylaze)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Anifrolumab (Saphnelo)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Anacaulase","No human target",TRUE,NA,NA,NA,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Aducanumab (Aduhelm)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Tremelimumab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Teplizumab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Abrocitinib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Umbralisib (Ukoniq)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Ropeginterferon alfa-2b (Besremi)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Odevixibat (Bylvay)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Maralixibat (Livmarli)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Finerenone (Kerendia)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Tisotumab vedotin (Tivdak)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Teclistamab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Talquetamab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Dasiglucagon (Zegalogue)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Belzutifan (Welireg)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Vosoritide (Voxzogo)","Other indication",FALSE,NA,TRUE,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Deucravacitinib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Faricimab",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Inclisiran (Leqvio)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Dostarlimab (Jemperli)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Mitapivat",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Trilaciclib (Cosela)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Dexmethylphenidate; serdexmethylphenidate (Azstarys)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Tralokinumab (Adbry)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Momelotinib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Vericiguat (Verquvo)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Pacritinib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Lonapegsomatropin (Skytrofa)","Other indication",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Ganaxolone",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tirzepatide",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tivozanib (Fotivda)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Avalglucosidase alfa (Nexviazyme)","Other indication",FALSE,TRUE,TRUE,0.991954133440882,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Infigratinib (Truseltiq)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Tepotinib (Tepmetko)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Asciminib (Scemblix)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Olutasidenib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Lecanemab",NA,FALSE,TRUE,TRUE,0.951397496038773,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Donanemab",NA,FALSE,TRUE,TRUE,0.951397496038773,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Vutrisiran",NA,FALSE,TRUE,TRUE,0.985702485030815,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Sotorasib (Lumakras)","Oncology",FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Adagrasib",NA,FALSE,NA,NA,0,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Tofersen",NA,FALSE,TRUE,TRUE,0.993957066521561,"Uniprot (variants)","Rare mendelian",2023
"uniprot_variants","Mavacamten",NA,FALSE,TRUE,TRUE,0.995966686845765,"Uniprot (variants)","Rare mendelian",2022
"uniprot_variants","Mobocertinib (Exkivity)","Oncology",FALSE,TRUE,NA,0,"Uniprot (variants)","Rare mendelian",2021
"uniprot_variants","Amivantamab (Rybrevant)","Oncology",FALSE,TRUE,NA,0,"Uniprot (variants)","Rare mendelian",2021
